Re: Adjuvant Pembrolizumab Versus Observation in Muscle-Invasive Urothelial Carcinoma

Eur Urol. 2024 Nov 21:S0302-2838(24)02702-7. doi: 10.1016/j.eururo.2024.11.009. Online ahead of print.

¹ Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Jikei University School of Medicine, Tokyo, Japan. Electronic address: morikeiichiro29@gmail.com.
² Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
³ Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

No abstract available